HE-4 IN OVARIAN CANCER THERAPY MONITORING: COMPARISON WITH CA 125

被引：0
|
作者：
Molina, R. [1 ]
Escudero, J. M. [1 ]
Auge, J. M. [1 ]
Filella, X. [1 ]
Fuste, P. [1 ]
机构：
[1] Hosp Clin Barcelona, Biochem Lab, Dept Gynecol, Barcelona, Spain
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
76
引用
收藏
页码：6839 / 6839
页数：1
相关论文
共 50 条
  • [21] The combination of HE4 and CA-125 is superior to either marker alone for monitoring women with ovarian cancer
    Samborski, A.
    Blackman, A. M.
    Miller, M. C.
    David, S. MacLaughlan
    Jackson, A. L.
    Eklund, E.
    Messerlian, G.
    Moore, R. G.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 97 - 97
  • [22] CA 125, HE 4 AND ROMA-INDEX IN PATIENTS WITH EPITHELIAL OVARIAN CANCER
    Filipova, I.
    Chakalova, G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [23] Diagnostic performances of CA 125, HE4, and ROMA index in ovarian cancer
    Dikmen, Z. G.
    Colak, A.
    Dogan, P.
    Tuncer, S.
    Akbiyik, F.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2015, 36 (04) : 457 - 462
  • [24] Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer
    Kim, Boyeon
    Park, Yongjung
    Kim, Banseok
    Ahn, Hyo Jun
    Lee, Kyung-A
    Chung, Jae Eun
    Han, Sang Won
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (01)
  • [25] HE4 and CA125 in ovarian malignancy
    Perovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S62 - S62
  • [26] COMPARISON OF HE4, CA125, AND RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) IN THE PREDICTION OF OVARIAN CANCER IN KOREAN WOMEN
    不详
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 991 - 991
  • [27] CA 19.9 and useful complementary tumor marker in ovarian cancer: Comparison with HE4, CA 125 and ROMA in Gynaecological diseases
    Molina, R.
    Escudero, J. M.
    Auge, J. M.
    Filella, X.
    Torne, A.
    Pahisa, J.
    Rius, M.
    Martinez-Zamora, M. A.
    Fuste, P.
    Balasch, J.
    TUMOR BIOLOGY, 2012, 33 : 39 - 39
  • [28] Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
    Elham O Hamed
    Hydi Ahmed
    Osama B Sedeek
    Abeer M Mohammed
    Ali A Abd-Alla
    Hazem M Abdel Ghaffar
    Diagnostic Pathology, 8
  • [29] Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response
    Hamed, Elham O.
    Ahmed, Hydi
    Sedeek, Osama B.
    Mohammed, Abeer M.
    Abd-Alla, Ali A.
    Ghaffar, Hazem M. Abdel
    DIAGNOSTIC PATHOLOGY, 2013, 8
  • [30] HE4AS SPECIFIC MARKER FOR OVARIAN CANCER: COMPARISON WITH CA125 IN DIFFERENTIAL DIAGNOSIS OF OVARIAN CANCER AND GYNECOLOGICAL PELVIC BENIGN DISEASES
    Zhang Lin
    Liu Zhongjuan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S282 - S282
12345